iCLAS™ for Persistent Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 215 participants.
Also called NCT04061603
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 215 participants
- Sponsor
- Registry
-
NCT04061603
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Belgium, Canada, Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT04061603. Allocation not applicable; no masking; primary purpose treatment. Start 2019-12-09 (actual); primary completion 2023-08-30 (actual). Results posted on 2026-08-06.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- iCLAS™ for Persistent Atrial Fibrillation
- Condition
- Persistent Atrial Fibrillation
- Intervention (Device)
- Adagio AF Cryoablation System (iCLAS™)
- Lead sponsor
- Adagio Medical
Record details
- Record id
cardio:ct-nct04061603- Content hash
297dbc51f70d52e7e60ec431dc3d56db7dd1cca65376c2a48792f56d34dd1e88